The pharmaceutical and life sciences industries have undergone a major digital transformation over the last decade. Batch records, laboratory notebooks, validation protocols, equipment logs, and approval workflows that were once maintained on paper are now managed through computerized systems. As organizations move toward paperless operations, electronic records and electronic signatures (ERES) have become critical components of Computer System Validation (CSV) and regulatory compliance.
However, simply replacing paper with software is not enough. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) expect companies to prove that their electronic records are trustworthy, secure, and equivalent to paper records. They also expect electronic signatures to be uniquely attributable to the individual who signed the record and protected against misuse.
For companies operating in GMP-regulated environments, understanding 21 CFR Part 11 compliance, audit trails, data integrity, and validated electronic signature controls is essential for avoiding inspection findings and maintaining an audit-ready state.
At Auxochromofours, we support pharmaceutical, biotech, and medical device organizations with CSV consulting, 21 CFR Part 11 assessments, audit trail reviews, and data integrity remediation to ensure electronic record systems remain compliant throughout their lifecycle.
What Are Electronic Records?
An electronic record is any information that is created, modified, maintained, archived, retrieved, or transmitted in digital form. In regulated environments, electronic records are far more than simple files stored on a computer. They are controlled GMP documents that may be used to make quality decisions, release products, or support regulatory submissions. Because these records are managed through computerized systems, organizations should also understand how Computer System Assurance (CSA) differs from traditional CSV and how a risk-based assurance approach can improve validation efficiency while maintaining compliance.
Examples of electronic records include:
Electronic batch manufacturing records (eBMR)
Laboratory analytical results from chromatography or spectroscopy systems
Validation protocols and summary reports
Audit trail logs
Equipment calibration and maintenance records
Change control and deviation records
CAPA documentation
Training records and competency assessments
Electronic regulatory submission files
These records must remain accurate, complete, consistent, and retrievable for the entire retention period defined by regulatory and business requirements.
Why Record Integrity Is So Important
If a laboratory result is changed without documentation, or if a batch record cannot be retrieved during an FDA inspection, the agency may question the reliability of the entire quality system. This is why regulators place significant emphasis on data integrity and require companies to implement technical and procedural controls that prevent unauthorized changes.
What Is an Electronic Signature?
An electronic signature is a computer-generated code, symbol, or process that is legally linked to an electronic record and executed by an individual with the intent to sign that record.
In practice, an electronic signature is used when a person:
Approves a batch record
Reviews laboratory results
Authorizes a validation report
Closes a deviation or CAPA
Approves a change control
Certifies that an activity was performed according to procedure
The signature must clearly identify who signed, when they signed, and what the signature means (for example, review, approval, authorship, or responsibility).
Types of Electronic Signatures
Non-biometric signatures are the most common in pharmaceutical systems and typically require a unique user ID and password.
Biometric signatures use physical characteristics such as fingerprints or iris scans and are less common in GMP environments.
Digital signatures use cryptographic encryption and digital certificates to bind the signature to the record and detect any subsequent modification.
Electronic Signature vs. Digital Signature
A common misconception is that electronic and digital signatures are the same thing.
Electronic signature | Digital signature |
Broad legal concept | Specific cryptographic technology |
Indicates intent to sign | Verifies identity and record integrity |
May use passwords or biometrics | Uses encryption and digital certificates |
Accepted under 21 CFR Part 11 | Provides stronger tamper detection |
Every digital signature is an electronic signature, but many compliant pharmaceutical systems use password-based electronic signatures rather than full cryptographic digital signatures.
Understanding 21 CFR Part 11
21 CFR Part 11 is the FDA regulation that defines the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. The regulation applies to systems used to create, modify, maintain, archive, retrieve, or transmit regulated records.
It is closely linked to GMP requirements, data integrity expectations, and GAMP 5-based Computer System Validation (CSV) practices , which provide a risk-based framework for validating computerized systems in pharmaceutical and life sciences organizations.
Key Compliance Requirements
System Validation
The system must be validated to demonstrate accuracy, reliability, and consistent performance. Validation activities typically include:
User Requirements Specification (URS)
Risk assessment
Functional and design specifications
IQ, OQ, and PQ testing
Traceability matrix
Validation summary report
Accurate and Complete Copies
The system must be able to generate complete copies of records in both human-readable and electronic formats for inspection and review.
Record Protection
Records must be protected against accidental deletion, unauthorized modification, and data corruption. Backup and disaster recovery procedures should be documented and periodically tested.
Access Control
Access must be restricted to authorized individuals. Shared accounts should never be used because they prevent attribution of actions to a specific person.
Audit Trails
The system must maintain secure, computer-generated, time-stamped audit trails that independently record operator actions and changes to data.
Authority Checks
Only individuals with the appropriate permissions should be able to create, modify, approve, or sign records.
Audit Trails: The Heart of Data Integrity
An audit trail is a secure chronological record of all actions performed within a system. It provides visibility into who did what, when they did it, and what changed.
A compliant audit trail should capture:
User ID
Date and time
Original value
New value
Reason for change (where applicable)
Signature or approval information
For example, if a laboratory analyst changes an integration parameter in chromatography software, the audit trail should record the original parameter, the updated value, the analyst’s identity, and the reason for the change.
ALCOA+ Principles
Audit trails support the ALCOA+ principles of data integrity:
Attributable
Legible
Contemporaneous
Original
Accurate
Complete
Consistent
Enduring
Available
FDA inspectors frequently review audit trails to identify backdated entries, deleted data, or unexplained modifications.
Best Practices for Managing Electronic Records and Signatures
Use Role-Based Access Control
Users should only have access to the functions necessary for their job responsibilities. Segregation of duties helps prevent unauthorized approvals or data changes.
Enforce Strong Authentication
Implement unique user accounts, strong password policies, and multi-factor authentication where appropriate.
Protect Signed Records
Once a record is signed, it should become read-only or require a controlled amendment process that generates a new audit trail entry and signature.
Train Personnel
Employees must understand the legal significance of electronic signatures and their personal responsibility when signing a record.
Review Audit Trails Regularly
Periodic audit trail review is essential for detecting unusual activity, unauthorized changes, or procedural noncompliance.
Maintain Validated State
Any software update, configuration change, or infrastructure modification should be evaluated through change control and assessed for validation impact.
Common Compliance Gaps
Organizations often receive observations for:
Shared user accounts
Disabled audit trails
Unvalidated spreadsheets used for GMP calculations
Inadequate backup procedures
Missing signature manifestations
Poor documentation of system changes
Failure to review audit trail events
These issues can lead to FDA Form 483 observations, warning letters, data integrity investigations, and costly remediation programs. Organizations developing or managing software in regulated environments should also understand the differences between IEC 62304 and Computer System Validation (CSV) to ensure that both software lifecycle activities and validation requirements are addressed appropriately.
How Auxochromofours Can Help
Auxochromofours provides end-to-end support for electronic record and electronic signature compliance, including:
21 CFR Part 11 gap assessments
EU Annex 11 compliance reviews
Computer System Validation (CSV)
Audit trail assessments
Data integrity investigations
Electronic signature implementation
Periodic review programs
Inspection readiness support
Our team helps organizations establish compliant, secure, and efficient digital quality systems that can withstand regulatory scrutiny.
Learn more about our Computer System Validation (CSV) services .
Final Thoughts
Electronic records and electronic signatures are now fundamental to modern pharmaceutical and life sciences operations. They enable faster approvals, improved traceability, reduced paperwork, and better collaboration across quality, manufacturing, and laboratory functions.
The real challenge is not adopting digital systems, it is ensuring those systems are validated, secure, and compliant with 21 CFR Part 11, EU Annex 11, and global data integrity expectations.
A strong CSV program, combined with effective audit trail controls and robust electronic signature procedures, helps organizations maintain trustworthy records, inspection readiness, and long-term regulatory compliance. Companies that invest in these controls are better positioned to reduce compliance risk, improve operational efficiency, and support successful regulatory inspections and submissions.
FAQs
1. What are electronic records in a pharmaceutical environment?
Electronic records are digital documents and data created, modified, stored, or transmitted by computerized systems. Examples include batch records, laboratory results, validation reports, audit trails, change controls, and training records.
2. What is an electronic signature under 21 CFR Part 11?
An electronic signature is a computer-generated symbol, code, or process that is legally linked to an electronic record and executed by an individual with the intent to sign. It is considered equivalent to a handwritten signature when Part 11 requirements are met.
3. What is the difference between an electronic signature and a digital signature?
An electronic signature is a broad legal concept that indicates intent to sign electronically. A digital signature is a specific technology that uses cryptographic encryption and digital certificates to verify identity and protect the record from tampering.
4. Why is Computer System Validation (CSV) important for electronic records?
CSV provides documented evidence that a computerized system performs as intended and consistently produces accurate, reliable, and secure records. Without validation, electronic records may not be considered trustworthy during regulatory inspections.
5. What is an audit trail and why is it required?
An audit trail is a secure, time-stamped record of all actions performed within a system, including record creation, modification, deletion, and approval. It is required to support data integrity and provide traceability for regulatory review.
6. Can electronic records be changed after they are signed?
Yes, but any change must follow a controlled process. The system should generate a new audit trail entry, timestamp, and, where applicable, require a new electronic signature to document the modification.
7. What are the most common 21 CFR Part 11 compliance issues?
Common issues include shared user accounts, disabled audit trails, inadequate access controls, unvalidated software, poor backup procedures, and failure to review audit trail events regularly.
8. How can Auxochromofours help with electronic record and signature compliance?
Auxochromofours provides 21 CFR Part 11 assessments, EU Annex 11 gap analyses, CSV documentation (URS, FS, IQ, OQ, PQ), audit trail reviews, data integrity consulting, electronic signature implementation support, and inspection readiness services for regulated organizations.